The overall goal of the MSGPP Program Project will be to determine crystal structures of biomedically important proteins of pathogenic protozoa in complex with small-molecule ligands. Project 1 will be indispensable to and tightly integrated into the overall Program.
Aim 1 of Project 1 will be to select 300 protein targets from ten pathogenic protozoa (including four Biodefense Category B Priority Pathogens) that will be the focus of all downstream efforts. Genomic data from ten microorganisms will be analyzed for """"""""high-value"""""""" targets that are predicted to be good for drug development. Target selection will also involve input from the outside scientific community. Scientists in Aim 2 will apply computational domain prediction to the proteins so that the expression laboratory (Project 2) can express smaller protein units or variants in order to achieve high success rates for soluble expression and crystallization (Project 3).
In Aim 3, experimental ligand discovery will be carried out before and after protein structures are determined. Strategies to discovering small-molecule ligands will include a) in-house frontal affinity chromatography with diverse compound libraries, b) small-molecule microarray screens (through collaboration), and c) submission of protein targets to NIH molecular screening centers.
Aim 3 will include chemical synthesis capabilities. Compounds that are known to act on the selected targets (so called """"""""piggy-back"""""""" compounds) will be obtained from outside sources.
In Aim 4, in silico ligand discovery will be carried out after the initial structure determination of target proteins. Databases of commercially available drug-like compounds will be docked into all protein pockets of functional significance. The high-scoring ligands will be purchased, assayed for binding, and subsequently included in co-crystallization or """"""""soaking"""""""" experiments. Project 1 will coordinate with the other components of the Program Project through an integrated computer database. There will be continual feedback within the units of Project 1, with the other components of the Program Project, and with outside collaborators to help achieve the Program goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI067921-02
Application #
7425439
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
2
Fiscal Year
2007
Total Cost
$516,831
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
PedrĂ³-Rosa, Laura; Buckner, Frederick S; Ranade, Ranae M et al. (2015) Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening. J Biomol Screen 20:122-30
Koh, Cho Yeow; Kim, Jessica E; Napoli, Alberto J et al. (2013) Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design. Mol Biochem Parasitol 189:26-32
Ranade, Ranae M; Gillespie, J Robert; Shibata, Sayaka et al. (2013) Induced resistance to methionyl-tRNA synthetase inhibitors in Trypanosoma brucei is due to overexpression of the target. Antimicrob Agents Chemother 57:3021-8
Shibata, Sayaka; Gillespie, J Robert; Ranade, Ranae M et al. (2012) Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization. J Med Chem 55:6342-51
Larson, Eric T; Ojo, Kayode K; Murphy, Ryan C et al. (2012) Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. J Med Chem 55:2803-10
Koh, Cho Yeow; Kim, Jessica E; Shibata, Sayaka et al. (2012) Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection. Structure 20:1681-91
Zucker, Frank H; Kim, Hae Young; Merritt, Ethan A (2012) PROSPERO: online prediction of crystallographic success from experimental results and sequence. J Appl Crystallogr 45:598-602
Johnson, Steven M; Murphy, Ryan C; Geiger, Jennifer A et al. (2012) Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. J Med Chem 55:2416-26
Larson, Eric T; Kim, Jessica E; Napuli, Alberto J et al. (2012) Structure of the prolyl-tRNA synthetase from the eukaryotic pathogen Giardia lamblia. Acta Crystallogr D Biol Crystallogr 68:1194-200
Ojo, Kayode K; Arakaki, Tracy L; Napuli, Alberto J et al. (2011) Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3. Mol Biochem Parasitol 176:98-108

Showing the most recent 10 out of 33 publications